Clinuvel Pharmaceuticals
CUV.AX
#7507
Rank
C$0.56 B
Marketcap
C$11.27
Share price
-3.68%
Change (1 day)
0.85%
Change (1 year)

Earnings for Clinuvel Pharmaceuticals (CUV.AX)

Earnings in 2024: C$46.53 Million

According to Clinuvel Pharmaceuticals's latest financial reports the company's current earnings are C$58.85 Million. In 2024 the company made an earning of C$46.53 Million, an increase over its 2023 earnings that were of C$41.79 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clinuvel Pharmaceuticals from 2000 to 2024

Annual earnings

Year Earnings Change
2024C$46.53 M11.35%
2023C$41.79 M28.31%
2022C$32.57 M22.8%
2021C$26.52 M112.63%
2020C$12.47 M-28.73%
2019C$17.5 M32.79%
2018C$13.18 M75.41%
2017C$7.51 M-332.52%
2016-C$3.24 Million-70.68%
2015-C$11.03 Million53.78%
2014-C$7.17 Million-16.1%
2013-C$8.55 Million-37.92%
2012-C$13.77 Million-18.19%
2011-C$16.83 Million25.31%
2010-C$13.43 Million-21.53%
2009-C$17.12 Million-11.27%
2008-C$19.29 Million80.4%
2007-C$10.7 Million-2.46%
2006-C$10.96 Million-5.35%
2005-C$11.58 Million60.55%
2004-C$7.22 Million97.37%
2003-C$3.66 Million50.62%
2002-C$2.43 Million121.22%
2001-C$1.1 Million254.48%
2000-C$0.31 Million